Use of urokinase in the treatment of tuberculous meningitis hydrocephalus
Neurosciences. 2009; 14 (1): 75-77
in English
| IMEMR
| ID: emr-92231
ABSTRACT
We present a patient with hydrocephalus after tuberculous meningitis successfully treated with urokinase. She presented with multiple episodes of headache, fever, and vomiting. She underwent external ventricular drainage and was treated with urokinase in addition to dexamethasone, acetazolamide, and 4 antituberculous drugs. She was evaluated clinically, radiologically, and by laboratory work-up. On short-term clinical follow-up [3 months], she was asymptomatic after the treatment with urokinase. She was radiologically evaluated 3 weeks after the treatment. An MRI of the brain showed a decrease in ventricular size. Urokinase can be considered as a safe and promising adjunctive treatment for tuberculous meningitis hydrocephalus
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Tuberculosis, Meningeal
/
Urokinase-Type Plasminogen Activator
/
Treatment Outcome
/
Hydrocephalus
/
Antitubercular Agents
Type of study:
Case report
Limits:
Female
/
Humans
Language:
English
Journal:
Neurosciences
Year:
2009
Similar
MEDLINE
...
LILACS
LIS